Finasteride as a Neo-Adjuvant Treatment for TURP: Literature Review

    February 2016 in “ Journal of urology and nephrology open access ”
    Doaa Attia, Ahmed Kotb
    Image of study
    TLDR Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.
    The literature review conducted by Attia D, Kotb AF in 2016 examined the role of Finasteride, a selective 5 Alpha Reductase Inhibitor, in decreasing blood loss associated with Transurethral Resection of the Prostate (TURP). The review found that Finasteride is an effective drug that can be considered pre-TURP for patients with a prostatic volume of more than 30 cc. The duration of treatment ranges from 1-6 weeks depending on the prostatic volume. The drug works by preventing the conversion of testosterone to Dihydrotestosterone (DHT), which leads to a decrease in symptoms of urethral obstruction and hematuria. Hematuria resolves within 1-2 weeks after treatment with Finasteride in 80% of patients. Preoperative treatment with Finasteride is essential to decrease perioperative bleeding and consequently to decrease the rate of postoperative complications.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 2 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Saying creatine causes loss on fin/dut makes no sense and this is why

      in Finasteride/Dutasteride  42 upvotes 9 months ago
      The conversation discusses whether creatine causes hair loss for those using finasteride or dutasteride, with some suggesting creatine might increase DHT or upregulate androgen receptors, potentially leading to hair loss. Others argue the evidence is not conclusive, citing limited studies and personal anecdotes, with some avoiding creatine as a precaution.

      community Just popped my first fin, excited as hell!

      in Finasteride/Dutasteride  154 upvotes 5 months ago
      A user shared their excitement about starting finasteride for hair loss after trying various ineffective methods. Other users discussed their experiences with finasteride, including shedding phases and side effects, with one mentioning using topical finasteride and minoxidil.

    Related Research

    2 / 2 results